Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome

Completed · Phase 4

Conditions studied: Turner Syndrome

In brief

This is an extension study that will gather long-term data on the effect of early growth hormone (GH) treatment on adult height and other aspects of health and development in girls with Turner syndrome. The main purpose is to determine whether girls who received 2 years of GH treatment before 6 years of age achieve taller adult height than girls who were untreated during this time. The study will also look at middle ear and hearing function, and cognitive and behavioral development. Protocol completion is defined as attainment of height velocity less than or equal to 1.0 cm/year, or bone age greater than or equal to 15 years.

Key facts

Study ID
NCT00266656
Run by
Eli Lilly and Company
People needed
69
Starts
2005-12-01
Expected to finish
2015-09-01
Last updated by the study team
2017-03-31

Who can join

Age: 4 and older, up to 20. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.